Brain Abscess Management

Diagnostic Approach

• Blood cultures are positive in approximately 28% of brain abscess cases, and HIV testing should be considered in all patients with non-traumatic brain abscess, according to the Clinical Microbiology and Infection guidelines 1
• Additional imaging, such as chest X-ray or CT of thorax-abdomen-pelvis, may be necessary to identify the primary source of infection in patients with brain abscess 1

Surgical Management

• Neurosurgical intervention is pivotal for source control in brain abscess management, and aspiration is the preferred neurosurgical procedure in most cases, as recommended by the Clinical Microbiology and Infection guidelines 2
• Excision may be considered in cases of brain abscess caused by difficult-to-treat pathogens, superficial brain abscesses in non-eloquent areas, or abscesses in the posterior fossa, according to the Clinical Microbiology and Infection guidelines 2
• Samples of pus should be sent for histopathological analyses and additional testing based on clinical presentation, such as tuberculosis, as recommended by the Clinical Microbiology and Infection guidelines 2

Monitoring and Follow-up

• Brain imaging should be performed immediately in case of clinical deterioration, and regular imaging intervals are sufficient after aspiration or excision until clinical cure is evident, as recommended by the Clinical Microbiology and Infection guidelines 3
• Repeated neurosurgical aspiration should be considered if clinical deterioration occurs, brain abscess enlarges, or no reduction in abscess volume is observed by 4 weeks after initial aspiration, according to the Clinical Microbiology and Infection guidelines 3
• It may take 3-6 months before residual contrast enhancement resolves on brain imaging, and it is often inappropriate to prolong antimicrobial treatment based solely on such radiological findings, as recommended by the Clinical Microbiology and Infection guidelines 3

Complications and Long-term Management

• Rupture of brain abscess carries substantially increased case-fatality rates, and long-term sequelae occur in approximately 45% of patients at 6 months after discharge, typically including focal neurological deficits and neurocognitive impairment, according to the Clinical Microbiology and Infection guidelines 3
• Referral to specialized neurorehabilitation is vital for managing long-term sequelae, and brain abscess is associated with substantially increased 1-year mortality compared to matched population controls, as recommended by the Clinical Microbiology and Infection guidelines 3
• There is an increased risk of cancer in patients with brain abscess history, necessitating a low threshold for diagnostic workup, according to the Clinical Microbiology and Infection guidelines 3

Special Considerations for Frontal Lobe Abscess

• Frontal lobe abscesses are associated with increased risk of epilepsy compared to other locations, as recommended by the Clinical Microbiology and Infection guidelines 2

Brain Abscess Management

Diagnostic Approach

• Brain MRI including diffusion-weighted imaging (DWI)/apparent diffusion coefficient (ADC) and T1-weighted imaging with and without gadolinium is strongly recommended as the preferred imaging modality for diagnosing brain abscess in patients with suspected brain infection, according to the Clinical Microbiology and Infection guidelines 4
• Molecular-based diagnostics are recommended when available, especially in patients with negative cultures, to identify the causative pathogens of brain abscess 4
• Antimicrobials may be withheld until aspiration or excision in patients without severe disease if neurosurgery can be performed within 24 hours of radiological diagnosis, as suggested by the Clinical Microbiology and Infection guidelines 5

Surgical Management

• Neurosurgical aspiration or excision is strongly recommended whenever feasible and should be performed as soon as possible to provide both diagnostic and therapeutic benefits, including confirming diagnosis, identifying causative pathogens, and reducing intracranial pressure and bacterial load 5
• Surgical intervention is recommended for patients with brain abscess, as it provides diagnostic and therapeutic benefits, including reducing intracranial pressure and bacterial load, and is associated with improved outcomes 4

Antimicrobial Therapy

• For community-acquired brain abscess in immunocompetent individuals, a 3rd-generation cephalosporin combined with metronidazole is strongly recommended as empirical treatment, according to the Clinical Microbiology and Infection guidelines 4
• The duration of antimicrobial therapy is recommended to be 6-8 weeks of intravenous antimicrobials for aspirated or conservatively treated brain abscesses, as suggested by the Clinical Microbiology and Infection guidelines 5

Adjunctive Therapies

• Corticosteroids, such as dexamethasone, are strongly recommended for management of severe symptoms due to perifocal edema or impending herniation in patients with brain abscess, according to the Clinical Microbiology and Infection guidelines 4

Complications and Special Considerations

• Rupture of brain abscess carries substantially increased case-fatality rates (27-50%) and may require external ventricular drainage for obstructive hydrocephalus, as reported by the Clinical Microbiology and Infection guidelines 6
• Long-term sequelae occur in approximately 45% of patients at 6 months after discharge, typically including focal neurological deficits and neurocognitive impairment, and referral to specialized neurorehabilitation is vital for managing these sequelae 6
• Brain abscess is associated with substantially increased 1-year mortality compared to matched population controls, and there is an increased risk of cancer in patients with brain abscess history, necessitating a low threshold for diagnostic workup 6

Surgical Intervention for Brain Abscess Based on Size

Size-Based Surgical Decision Algorithm

• Neurosurgical aspiration or excision should be performed for brain abscesses ≥2.5 cm in diameter, as this threshold is consistently associated with improved mortality outcomes and represents the standard for surgical intervention, with an odds ratio of 0.5 (95% CI 0.3-0.6) favoring surgery 7, 8, 9, 10
• Surgical intervention at this size reduces mortality from 24% (conservative management) to 9% (surgical management) 7, 8, 9, 10
• Even small abscesses can now be accessed via stereotactic-guided minimally invasive techniques, particularly when located deep within the brain 7, 9
• Proceed with surgical drainage regardless of size if located in critical areas, causing significant mass effect, or close proximity to ventricles (high rupture risk) 8, 10
• Proceed with surgical drainage regardless of size if the patient shows clinical deterioration 11

Critical Nuances in Surgical Decision-Making

• The European Society of Clinical Microbiology and Infectious Diseases guidelines emphasize that neurosurgical intervention should be performed "as soon as possible in all patients whenever feasible" 7, 8
• Abscess location, such as deep-seated abscesses, is a critical factor in surgical decision-making, with higher mortality but now accessible via stereotactic techniques 7, 8

Monitoring and Repeat Intervention

• Repeat imaging every 2 weeks until clinical cure is evident, and lack of regression by 4 weeks is unusual 11
• Repeat aspiration or excision is required if clinical deterioration occurs, abscess enlarges on imaging, or no reduction in abscess volume by 4 weeks after initial aspiration, with approximately 21% of aspiration cases and 6% of excision cases requiring repeat procedures 7, 8, 11

Common Pitfalls to Avoid

• Rupture occurs in 10-35% of brain abscess cases and carries 27-50% mortality, with close proximity to ventricles being a key risk factor for rupture, warranting earlier surgical intervention regardless of size 8, 10, 11
• Residual contrast enhancement may persist for 3-6 months after clinical cure, and antimicrobial therapy should not be prolonged based solely on radiological findings after clinical improvement is evident 11

Management of KPC‑Producing Klebsiella pneumoniae Brain Abscess

Surgical Intervention

• Early neurosurgical aspiration (ideally ≤ 24 h after diagnosis) reduces mortality from ~24 % to ~9 % and supplies material for culture‑directed therapy 12.
• Aspiration is preferred over excision in most cases because it lowers intracranial pressure, decreases bacterial load, and provides diagnostic pus samples 12.
• If aspiration is performed, the specimen should be sent for aerobic and anaerobic cultures, histopathology, and stored for molecular diagnostics when initial cultures are negative 12.
• Excision may be considered for superficial abscesses located in non‑eloquent brain regions or in the posterior fossa 12.

Antimicrobial Therapy

• Empiric combination regimen: high‑dose meropenem (2 g IV every 8 h as prolonged infusion) + polymyxin B or colistin + tigecycline provides superior outcomes compared with monotherapy** 13.
• Therapeutic drug monitoring (TDM) of meropenem, polymyxins, and aminoglycosides is recommended to optimize CNS penetration and limit nephrotoxicity 13.
• Prolonged‑infusion high‑dose meropenem achieves better cerebrospinal fluid penetration even when the isolate is carbapenem‑resistant 13.

Duration of Antimicrobial Therapy

• A total of 6–8 weeks of intravenous antimicrobial therapy is advised for aspirated brain abscesses 12.
• Extending therapy beyond 6–8 weeks solely on the basis of residual contrast enhancement is discouraged, as imaging abnormalities may persist for 3–6 months after clinical cure 12.

Interpretation of CSF Findings

• Neutrophilic pleocytosis in CSF is typical of bacterial brain abscess and can mimic other CNS infections; it should not be mistaken for viral or autoimmune processes 14.
• In KPC‑producing infections, CSF neutrophilic pleocytosis, elevated protein, and low glucose are common and resemble bacterial meningitis 15.
• Persistent neutrophilic pleocytosis does not exclude the presence of a brain abscess in bacterial CNS infections 16.
• Marked peripheral neutrophilia reflects the systemic inflammatory response to severe bacterial infection 15.

Monitoring and Follow‑up

• Repeat brain MRI every 2 weeks until clinical cure is evident; if no reduction in abscess volume is seen by 4 weeks, repeat aspiration should be planned 12.
• Immediate neuro‑imaging is required for any clinical deterioration 12.
• Failure of abscess regression by 4 weeks mandates repeat surgical intervention 12.